<unk>  (INN) is a potent Rho-kinase inhibitor and vasodilator. Since it was discovered, it has been used for the treatment of cerebral vasospasm, which is often due to subarachnoid hemorrhage, as well as to improve the cognitive decline seen in stroke patients. It has been found to be effective for the treatment of pulmonary hypertension. It has been demonstrated that<unk>  could improve memory in normal mice, identifying the drug as a possible treatment for age-related or neurodegenerative memory loss. It has been approved for use in Japan and China since 1995, but has not been approved by the United States Food and Drug Administration or by the European Medicines Agency. Woolsey Pharmaceuticals is developing BRAVYL (oral<unk>  for various neurodegenerative diseases.
Fasudil
Lesinurad
Vagisil
Tezacaftor
Telotristat ethyl
Snoezelen
Belumosudil
Ramelteon